Post-earnings recap
Reported
Thu, Oct 24, 2024
EPS actual
$0.34
EPS est.
$0.43
EPS surprise
-21.84%
1-day move
+3.27%
Dexcom's earnings report showed a significant EPS miss, but the stock still reacted positively, rising by 3.27%. This increase may reflect investor optimism about the company's future prospects and ongoing product demand. Management's comments suggest they remain focused on innovation and market growth despite the current challenges.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.34 | N/A | -21.84% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in the company's long-term strategy while acknowledging the challenges faced in the current quarter.
Management highlighted ongoing product demand despite the EPS miss.
They emphasized their commitment to innovation and market expansion.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—